Pharmacokinetics of liposomal amphotericin B in pleural fluid

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 4, 2010, Pages 1633-1635

  Moriyama, Brad ^a   Torabi Parizi, Parizad ^b   Pratt, Alexandra K ^b   Henning, Stacey A ^a   Pennick, Gennethel ^c   Shea, Yvonne R ^d   Chowdhuri, Sinchita Roy ^e   Rinaldi, Michael G ^c   Barrett, A John ^f   Walsh, Thomas J ^e  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Critical Care Medicine Department   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d Department of Laboratory Medicine ^*  (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; METHYLPREDNISOLONE;

ACINETOBACTER INFECTION; ADULT; AREA UNDER THE CURVE; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG PENETRATION; FEMALE; FUNGUS IDENTIFICATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG RESECTION; MUCORMYCOSIS; MULTIPLE ORGAN FAILURE; PLASMA CONCENTRATION-TIME CURVE; PLEURA EMPYEMA; PLEURA FLUID; PRIORITY JOURNAL; SEPTIC SHOCK; THORACOTOMY; THORAX DRAINAGE; TREATMENT DURATION;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; EMPYEMA, PLEURAL; FEMALE; HUMANS; LIPOSOMES; LUNG DISEASES, FUNGAL; MIDDLE AGED; MUCORMYCOSIS; PLEURAL EFFUSION;

EID: 77950131850     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01438-09     Document Type: Article

References (22)

1. Bindschadler, D. D., and J. E. Bennett. 1969. A pharmacologic guide to the clinical use of amphotericin B. J. Infect. Dis. 120:427-436.
2. Chabot, G. G., R. Pazdur, F. A. Valeriote, and L. H. Baker. 1989. Pharmacokinetics and toxicity of continuous infusion amphotericin B in cancer patients. J. Pharm. Sci. 78:307-310.
3. Chamilos, G., E. M. Marom, R. E. Lewis, M. S. Lionakis, and D. P. Kontoyiannis. 2005. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin. Infect. Dis. 41:60-66.
4. Chamilos, G., M. Luna, R. E. Lewis, G. P. Bodey, R. Chemaly, J. J. Tarrand, A. Safdar, I. I. Raad, and D. P. Kontoyiannis. 2006. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 91:986-989.
5. Cooke, D. T., F. D. Pagani, D. R. Kaul, K. R. Cooke, C. L. Lau, and J. Riddell IV. 2009. Successful treatment of pulmonary zygomycosis in two transplant recipients with liposomal amphotericin B and partial surgical resection followed by posaconazole. Mycoses 53:163-167.
6. Espinel-Ingroff, A. 2001. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J. Clin. Microbiol. 39:954-958.
7. Horowitz, I. D., E. A. Blumberg, and L. Krevolin. 1993. Cryptococcus albidus and mucormycosis empyema in a patient receiving hemodialysis. South. Med. J. 86:1070-1072.
8. Kimura, M., S. I. Udagawa, K. Makimura, K. Satoh, N. Toyazaki, and H. Ito. 2009. Isolation and identification of Rhizomucor pusillus from pleural zygomycosis in an immunocompetent patient. Med. Mycol. 47:869-873.
9. Ko, S. C., K. Y. Chen, P. R. Hsueh, K. T. Luh, and P. C. Yang. 2000. Fungal empyema thoracis: an emerging clinical entity. Chest 117:1672-1678.
10. Krauze, A., K. Krenke, M. Matysiak, and M. Kulus. 2005. Fatal course of pulmonary Absidia sp. infection in a 4-year-old girl undergoing treatment for acute lymphoblastic leukemia. J. Pediatr. Hematol. Oncol. 27:386-388.
11. Kutty, K., and J. C. Neicheril. 1987. Treatment of pleural blastomycosis: penetration of amphotericin B into the pleural fluid. J. Infect. Dis. 156:689-690.
12. Lai, C. C., S. J. Liaw, Y. C. Hsiao, Y. S. Chiu, W. Y. Laio, L. N. Lee, and P. R. Hsueh. 2006. Empyema thoracis due to Rhizopus oryzae in an allogenic bone marrow transplant recipient. Med. Mycol. 44:75-78.
13. Munipalli, B., M. G. Rinaldi, and S. B. Greenberg. 1996. Cokeromyces recurvatus isolated from pleural and peritoneal fluid: case report. J. Clin. Microbiol. 34:2601-2603.
14. Pyrgos, V., S. Shoham, and T. J. Walsh. 2008. Pulmonary zygomycosis. Semin. Respir. Crit. Care Med. 29:111-120.
15. Roden, M. M., T. E. Zaoutis, W. L. Buchanan, T. A. Knudsen, T. A. Sarkisova, R. L. Schaufele, M. Sein, T. Sein, C. C. Chiou, J. H. Chu, D. P. Kontoyiannis, and T. J. Walsh. 2005. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin. Infect. Dis. 41:634-653.
16. Spellberg, B., T. J. Walsh, D. P. Kontoyiannis, J. Edwards, Jr., and A. S. Ibrahim. 2009. Recent advances in the management of mucormycosis: from bench to bedside. Clin. Infect. Dis. 48:1743-1751.
17. Walsh, T. J., J. L. Goodman, P. Pappas, I. Bekersky, D. N. Buell, M. Roden, J. Barrett, and E. J. Anaissie. 2001. Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentus fungi: maximum tolerated dose study. Antimicrob. Agents Chemother. 45:3487-3496.
18. Wang, L. H., P. C. Smith, K. L. Anderson, and R. M. Fielding. 1992. High-performance liquid chromatographic analysis of amphotericin B in plasma, blood, urine and tissues for pharmacokinetic and tissue distribution studies. J. Chromatogr. 579:259-268.
19. Wang, N. S. 1985. Anatomy and physiology of the pleural space. Clin. Chest Med. 6:3-16.
20. Weiler, S., R. Bellmann-Weiler, M. Joannidis, and R. Bellmann. 2007. Penetration of amphotericin B lipid formulations into pleural effusion. Antimicrob. Agents Chemother. 51:4211-4213.
21. Weiler, S., R. Bellmann-Weiler, S. Dunzendorfer, M. Joannidis, and R. Bellmann. 2008. Levels of amphotericin B lipid formulations in ascites. J. Antimicrob. Chemother. 62:1163-1164.
22. Zocchi, L. 2002. Physiology and pathophysiology of pleural fluid turnover. Eur. Respir. J. 20:1545-1558.